This recommendation is unchanged from the 2017 ASCO Sentinel Lymph Node Biopsy for Patients with Early-Stage Breast Cancer 3 and the 2021 joint Ontario Health (OH; Cancer Care Ontario)-ASCO Management ...

Objectives Infliximab, an anti-TNF agent, is used to treat sarcoidosis that does not respond to corticosteroids or second-line agents. The efficacy of other anti-TNF agents, non-TNF biologics and ...

Among sarcoidosis third-line therapies, infliximab has proved modestly effective and efzofitimod shows promise for pulmonary disease, while tofacitinib and adalimumab may hold promise for treating ...

During clinical liver biopsy surgery, the high-precision and low-trauma advantages of the biopsy robot (BR) are hindered due to the interference of respiratory motion (RM). To mitigate the ...